Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.23.1
Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued consulting $ 423,464 $ 232,390
Accrued compensation 283,657 459,997
Accrued research and development 851,000 1,696,129
Accrued other 100 9,920
Total accrued expenses and other current liabilities $ 1,558,221 $ 2,398,436